Finance

Beta
Lists
AVE:ASX
Avecho Biotechnology Ltd
A$0.011
-8.33%
(-0.0010) 1D
Jun 3, 4:10:28 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for AVE...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
50.56M
Avg. vol.
11.49M
Volume
6.17M
52-wk high
A$0.01
52-wk low
A$0.00
EPS
-A$0.00
Shares outstanding
3.83B
No. of employees
15
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
50.56M
Avg. vol.
11.49M
Volume
6.17M
52-wk high
A$0.01
52-wk low
A$0.00
EPS
-A$0.00
Shares outstanding
3.83B
No. of employees
15
News stories
From sources across the web
About Avecho Biotechnology Ltd
CEOPaul Gavin Ph.D.
Employees15
Founded1992
Headquarters-
SectorPharmaceutical industry
Websiteavecho.com.au
Last report
Jan 28, 2026
Fiscal period
Q4 2025
EPS / Est. (AUD)
- / -
Revenue / Est. (AUD)
338.85K / -
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
280.04K
280.04K
338.85K
338.85K
Cost of goods sold
82.58K
82.58K
92.11K
92.11K
Cost of revenue
82.58K
82.58K
92.11K
92.11K
Research and development expenses
652.12K
652.12K
478.93K
478.93K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
849.01K
849.01K
441.76K
441.76K
Operating expense
1.50M
1.50M
920.69K
920.69K
Total operating expenses
1.58M
1.58M
1.01M
1.01M
Operating income
-1.30M
-1.30M
-673.96K
-673.96K
Other non operating income
-
-
-
-
EBT including unusual items
-1.34M
-1.34M
-870.33K
-870.33K
EBT excluding unusual items
-1.34M
-1.34M
-870.33K
-870.33K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.34M
-1.34M
-870.33K
-870.33K
Net profit margin
-477.79%
-477.79%
-256.85%
-256.85%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-34.30K
-34.30K
-196.38K
-196.38K
Net interest expenses
-34.30K
-34.30K
-196.38K
-196.38K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.27M
-1.27M
-639.62K
-639.62K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer